YaylaKGYaylaC. Cardiac Manifestations in Inflammatory Bowel Disease. Angiology. 2021; DOI 10.1177/0003319721991736 (article in press).
2.
KamperidisNKamperidisVZegkosT, et al.Atherosclerosis and Inflammatory Bowel Disease—Shared Pathogenesis and Implications for Treatment. Angiology. 2021;72:303–14.
3.
MitchellNEHarrisonNJungaZ, et al.Heart under attack: Cardiac manifestations of inflammatory bowel disease. Inflammatory Bowel Disease. 2018; 24: 2322–6.
4.
YorulmazESezginAYorulmazH, et al.Prolonged QT dispersion in inflammatory bowel disease. World J Gastroenterol. 2013; 19: 65–71
5.
DoganYSoyluAErenGA, et al.Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients. Int J Med Sci. 2011; 8: 540–6.
6.
ChoiYJChoiEKHanKD, et al.Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol. 2019;25:2788–98.
7.
KristensenSLLindhardsenJAhlehoffO, et al.Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: A nationwide study. Europace. 2014;16:477–84.
8.
MarcusGMWhooleyMAGliddenDVPawlikowskaLZaroffJGOlginJE. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the heart and soul study. Am Heart J. 2008;155:303–9.
9.
ScharrerSPrimasCEichingerS, et al.Inflammatory bowel disease and risk of major bleeding during anticoagulation for venous thromboembolism. Inflamm Bowel Dis. 2021; doi: 10.1093/ibd/izaa337 (Online ahead of print).
